86. Pulmonary arterial hypertension Clinical trials / Disease details


Clinical trials : 1,205 Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05179356
(ClinicalTrials.gov)
January 1, 202316/12/2021Dapagliflozin in Pulmonary Arterial HypertensionEffects of DAPAgliflozin on Cardiopulmonary Exercise Capacity and Hemodynamics in Pulmonary Arterial Hypertension: A Double Blind Randomized Trial. (DAPAH-trial)Pulmonary Arterial Hypertension;Chronic Thromboembolic Pulmonary HypertensionDrug: Dapagliflozin 10 MG [Farxiga];Drug: PlaceboMads ErsbøllNULLNot yet recruiting18 YearsN/AAll52Phase 2NULL